Acute Market Reports pharmaceuticals report, S-1 (Pancreatic Cancer) - Analysis and Forecasts to 2020 provides S-1 sales forecasts for Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2006-2020). The report also includes information on Pancreatic Cancer market.
This report is built using data and information sourced from Acute Market Reports proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Acute Market Reports team of industry experts.
Scope
Therapy area profile including patient population for Japan
Analysis and review of S-1 including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of S-1 including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecasts for 2006-2020 for S-1 in Japan
Therapy area profile including patient population for Japan
Analysis and review of S-1 including sales data
Qualitative and quantitative assessment of market space
Analysis of the trends, drivers and restraints shaping and defining the markets
In-depth analysis of S-1 including efficacy, safety, pricing, competition and other details which influence its sales potential
Detailed sales forecasts for 2006-2020 for S-1 in Japan
Reasons to buy
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of competition by understanding the changing competitive landscape
Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and in-depth analysis of the drugs performance
Examine the historical sales performance of a drug in seven major markets
Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Click Here To Download Detail Report: http://www.acutemarketreports.com/request-free-sample/36920
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Pancreatic Cancer 4
2.2 Pancreatic Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Cigarette Smoking 6
2.4.2 Age 6
2.4.3 Gender 7
2.4.4 Family History 8
2.4.5 Other Factors 8
2.5 Acute Market Reports Forecasts Report Guidance 9
2.1 Pancreatic Cancer 4
2.2 Pancreatic Cancer Market 4
2.3 Epidemiology 4
2.4 Etiology 6
2.4.1 Cigarette Smoking 6
2.4.2 Age 6
2.4.3 Gender 7
2.4.4 Family History 8
2.4.5 Other Factors 8
2.5 Acute Market Reports Forecasts Report Guidance 9
3 Pancreatic Cancer: Market Characterization 10
3.1 Pancreatic Cancer Market 10
3.2 Pancreatic Cancer Market Forecasts and CAGR 10
3.3 Drivers for Pancreatic Cancer Market 11
3.3.1 High Prevalence 11
3.3.2 High Incidence 11
3.3.3 Large Unmet Need 12
3.1 Pancreatic Cancer Market 10
3.2 Pancreatic Cancer Market Forecasts and CAGR 10
3.3 Drivers for Pancreatic Cancer Market 11
3.3.1 High Prevalence 11
3.3.2 High Incidence 11
3.3.3 Large Unmet Need 12
4 Tumor-Node-Metastases (TNM) Classification of Pancreatic Cancer 13
5 S-1 16
5.1 Introduction 16
5.2 Mechanism of Action 16
5.3 Clinical Studies 16
5.3.1 First line therapy in combination with gemcitabine 16
5.3.2 First line therapy in combination with concurrent radiotherapy 17
5.3.3 S-1 in second line as a monotherapy after gemcitabine failure 17
5.4 Approval History of S-1 18
5.5 Factors Affecting Sales of S-1 18
5.5.1 Pancreatic Cancer Market 18
5.5.2 High Efficacy 18
5.5.3 Low Cost of Treatment 18
5.5.4 Presence in Market Prior to Pancreatic Cancer Approval 18
5.5.5 Lack of Presence in the US and EU market 18
5.5.6 Low Toxicity 19
5.5.7 Benefit to Gemcitabine-Refractory Pancreatic Cancer 19
5.6 Drug Risk Benefit Score 19
5.6.1 Efficacy 20
5.6.2 Safety 20
5.6.3 Compliance 20
5.6.4 Dosing Convenience 20
5.7 Intensity of Competition 20
5.8 Sales Forecasts 20
5.8.1 Target Patient Pool of S-1 20
5.8.2 Dosing 21
5.8.3 Market Penetration 21
5.8.4 Annual Cost of Therapy 22
5.8.5 Sales Projections of S-1 22
5.1 Introduction 16
5.2 Mechanism of Action 16
5.3 Clinical Studies 16
5.3.1 First line therapy in combination with gemcitabine 16
5.3.2 First line therapy in combination with concurrent radiotherapy 17
5.3.3 S-1 in second line as a monotherapy after gemcitabine failure 17
5.4 Approval History of S-1 18
5.5 Factors Affecting Sales of S-1 18
5.5.1 Pancreatic Cancer Market 18
5.5.2 High Efficacy 18
5.5.3 Low Cost of Treatment 18
5.5.4 Presence in Market Prior to Pancreatic Cancer Approval 18
5.5.5 Lack of Presence in the US and EU market 18
5.5.6 Low Toxicity 19
5.5.7 Benefit to Gemcitabine-Refractory Pancreatic Cancer 19
5.6 Drug Risk Benefit Score 19
5.6.1 Efficacy 20
5.6.2 Safety 20
5.6.3 Compliance 20
5.6.4 Dosing Convenience 20
5.7 Intensity of Competition 20
5.8 Sales Forecasts 20
5.8.1 Target Patient Pool of S-1 20
5.8.2 Dosing 21
5.8.3 Market Penetration 21
5.8.4 Annual Cost of Therapy 22
5.8.5 Sales Projections of S-1 22
View all reports of this category @ http://www.acutemarketreports.com/category/pancreatic-cancer-market
6 Appendix 24
6.1 Market Definitions 24
6.2 Abbreviations 24
6.3 Research Methodology 24
6.3.1 Coverage 24
6.3.2 Secondary Research 25
6.3.3 Forecasting 25
6.3.4 Number of Patients Approved to take the Drug 25
6.3.5 Net Penetration of Drug 26
6.3.6 Net Annual Dosing 27
6.3.7 Annual Cost of Therapy 27
6.3.8 Primary Research 27
6.3.9 Expert Panels 27
6.4 Contact Us 28
6.5 Disclaimer 28
6.6 Sources 28
6.1 Market Definitions 24
6.2 Abbreviations 24
6.3 Research Methodology 24
6.3.1 Coverage 24
6.3.2 Secondary Research 25
6.3.3 Forecasting 25
6.3.4 Number of Patients Approved to take the Drug 25
6.3.5 Net Penetration of Drug 26
6.3.6 Net Annual Dosing 27
6.3.7 Annual Cost of Therapy 27
6.3.8 Primary Research 27
6.3.9 Expert Panels 27
6.4 Contact Us 28
6.5 Disclaimer 28
6.6 Sources 28
Latest Report: http://www.fpt2013.org/global-sutent-market-size/
About Us:
About Us:
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.
Our market research professionals have detailed knowledge of the publishers and different kinds of reports in their particular business domains. They will guide you in finding the complete range of available market research reports, review the scope and procedure of the research studies that you select, and provide you guidance in order to assist you in taking the correct business decisions related to the purchase of the market research reports.
Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: Acute Market Reports
Mr. Chris Paul
Office No 101, 1st Floor,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
Email: sales@acutemarketreports.com
Website: Acute Market Reports
No comments:
Post a Comment